Point of Care Diagnostics- Market Insights, Competitive Landscape and Market Forecast–2027
This report can be delivered to the clients within 7-10 Business Days
Point of Care Diagnostics Market By Product Type (Instruments, Reagents And Kits), By Application (Blood Glucose Monitoring, Infectious Disease, Cardio Metabolic Diseases, Pregnancy & Infertility Testing, And Others), By Technology (Lateral Flow Assays, Immunoassays, Molecular Diagnostics, And Others), By End-User (Hospitals, Diagnostic Centers, Home Care Settings, And Others), and by geography is estimated to register appreciable CAGR forecast till 2027 owing to the increasing prevalence of infectious diseases and rising technological advancements pertaining to the point of care diagnostic devices
Global Point of Care Diagnostics market was valued at USD 1.85 billion in 2021, growing at a CAGR of 7.99% during the forecast period from 2022 to 2027 to reach USD 2.93 billion by 2027. The demand for point of care diagnostics is primarily being boosted by the rising number of patients suffering from various infectious diseases, rising prevalence of diabetes, increasing frequency of both chronic and acute diseases, increasing demand of point of care kits in the diseases management of COVID-19 infection, and the increasing technological advancements associated with the Point of Care Diagnostic devices will help in driving the overall market growth of point of care diagnostics during the forecast period from 2022-2027.
Point of Care Diagnostics Market Dynamics:
The point of care diagnostics market is experiencing increase in product demand owing to a variety of factors. One of the important factors is the emergence of COVID-19. The rising prevalence of COVID-19 across the globe can be attributed to increase in demand of point of care diagnostic devices owing to the rising use of POC kits in COVID-19 detection. As per the World Health Organization February 28, 2022, there have been 434,154,739 confirmed cases of COVID-19, thereby there will be an increase in the demand of point of care, leading to an overall growth of the point of care devices market.
Furthermore, the rising number of patients having diabetes will also increase the demand of point of care diagnostic devices, further leading to an increase in the overall market growth of the point of care diagnostic devices. For instance, according to the International Diabetes Federation, in the year 2022, approximately 537 million adults (20-79 years) were suffering from diabetes. Also, as per the same source, the total number of people living with diabetes is projected to rise to 643 million by the year 2030 and 785 million by 2045 which will boost the market growth during the forecast period.
However, several stringent regulatory policies pertaining to the Point of Care Diagnostics and the inadequate adoption of point of care diagnostics may restrict the point of care diagnostics market growth.
The point of care diagnostics market has been affected positively after the emergence of the COVID-19 infection. Although the COVID-19 pandemic impact had been unforeseen and devastating, however the point of care diagnostics demand was positively influenced, as the POC diagnostic were rapidly used in the detection of COVID-19. The rapidly rising number of COVID-19 cases and the rising pressure on the government for improving patient management has further boosted the demand for rapid antigen testing kits that can be effectively used in point-of-care settings. Such rapidly detecting kit of point of care diagnostic are important in offering accurate disease management options. Therefore, owing to an increase in the demand for speedy diagnostic results, the adoption of point of care devices amongst the patients is continuously on the rise.
Point of Care Diagnostics Market Segment Analysis:
Point Of Care Diagnostics Market By Product Type (Instruments, Reagents and Kits), By Application (Blood Glucose Monitoring, Infectious Disease, Cardio Metabolic Diseases, Pregnancy & Infertility Testing, and Others), By Technology (Lateral Flow Assays, Immunoassays, Molecular Diagnostics, and Others), By End-User (Hospitals, Diagnostic Centers, Home Care Settings, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the application segment of the point of care diagnostics market, the infectious disease category is expected to amass a significant share in the market revenue during the forecast period. This can be ascribed to various factors such as the rising prevalence of COVID-19, rising product approvals pertaining to infectious diseases point of care diagnostics, rising research and development associated with POC kits that help in the diagnosis of infectious diseases across the world.
For example, as per the Our World in Data organization, in 2022, around 296 million people were living with chronic hepatitis B infection in the year 2019, affecting about 1.5 million people with infections every year. Owing to a rise in the population suffering from chronic hepatitis B, there will be an increase in the demand of point of care diagnostic devices, leading to an overall increase in the point of care diagnostics market growth.
Furthermore, as per the World Health Organization 2022, every year, an estimated 11-20 million people tend to get affected from typhoid and about 128,000 to 161,000 people were affected from it. Owing to an increase in the number of patients suffering from typhoid, there will be an increase in the demand of point of care diagnostic devices, driving the market growth of Point of Care Diagnostics.
Moreover, an increase in the number of product approvals used in the disease diagnosis of infectious diseases and other chronic diseases will also increase the demand of point of care diagnostics sued in disease assessment, leading to the overall growth of point of care diagnostic devices.
Thus, all the aforementioned factors are likely to propel the infectious diseases category growth in the point of care diagnostics devices market during the forecast period.
North America is expected to dominate the overall Point of Care Diagnostics Market:
Among all the regions, North America is estimated to account for the largest share in the point of care diagnostics market. Owing to the significance of key growth factors such as rising prevalence of geriatric population susceptible to developing chronic diseases such as infectious diseases owing to reduced immunity, increasing presence of key players in the region, favorable government scenario, rising awareness associated with self-testing and rising demand of home care testing, growing approvals for Point of Care Diagnostic devices in the North American region coupled with increasing focus of the government in terms of providing access to healthcare services catering to such indications will drive the market growth in the region.
Several collaborations and strategic partnerships between the key players, along with higher adoption of advanced rapid diagnostic solutions in the North American region will increase the demand of POC diagnostic solutions, leading to an overall increase in the market growth of point of care diagnostics market growth. Also, the continued investments made in research and development activities along with a strong portfolio of products in the point-of-care testing segment, are likely to continue fueling the instances of point of care diagnostics devices, thereby generating demand for Point of Care Diagnostics.
Furthermore, the rising emergency use authorization for expanded access will also contribute to the growing demand of point of care devices, causing the overall increase of the point of care devices market growth. For instance, on December 25, 2022, Roche COVID-19 at-home test had received FDA emergency use authorization to expand access for rapid self-testing solutions in the United States.
Furthermore, the rise in the number of patients suffering from diabetes will also lead to an increase in the demand of point of care diagnostics devices, thereby leading to an overall rise of the point of care diagnostics market growth. For instance, according to the Centers of Disease Control and Prevention 2022, in the year 2022, around 37.3 million people were suffering from diabetes, that had accounted to about 11.3% of the US population. As per the same source, in the year 2022, around 28.7 million people, accounting to about 28.5 million adults were diagnosed for diabetes in the United States.
Thus, all the above mentioned factors will lead to an increase in the North America Point of Care Diagnostics market.
Point of Care Diagnostics Market Key Players:
Some of the key market players operating in the point of care diagnostics market includes Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Becton Dickinson and Company, Abbott Laboratories, Quidel Diagnostics, Chembio Diagnostics, EKF Diagnostics, Trinity Biotech, and Fluxergy, Qiagen, Mesa Biotech, Cepheid, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Quidel Corporation, Bio-Rad Laboratories Inc. and others.
Recent Developmental Activities in Point of Care Diagnostics Market:
1. What are Point of Care Diagnostics Market?
Point of care (POC) diagnostic devices are used to obtain diagnostic results while with the patient or close to the patient. Used in doctors’ offices, hospitals, and in patients' homes, POC diagnostic devices give quick feedback on many sorts of medical tests.
2. What is the market for Global Point of Care Diagnostics Market?
Global point of care diagnostics market was valued at USD 1.85 billion in 2021, growing at a CAGR of 7.99% during the forecast period from 2022 to 2027 to reach USD 2.93 billion by 2027.
3. What are the drivers for Global Point of Care Diagnostics Market?
The demand for point of care diagnostics is primarily being boosted by increasing prevalence of infectious diseases, rising prevalence of pregnancies, rising technological advancements pertaining to the Point of Care Diagnostics, and the rising geriatric population associated with reduced immunity and a rise in infectious diseases thereby contributing in the overall growth of the point of care diagnostics market during the forecast period from 2022-2027.
4. Who are the key players operating in Global Point of Care Diagnostics Market?
Some of the key market players operating in the point of care diagnostics market includes Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Becton Dickinson and Company, Abbott Laboratories, Quidel Diagnostics, Chembio Diagnostics, EKF Diagnostics, Trinity Biotech, and Fluxergy, Qiagen, Mesa Biotech, Cepheid, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Quidel Corporation, Bio-Rad Laboratories Inc., and others.
5. Which region has the highest share in Point of Care Diagnostics Market?
North America is expected to dominate the overall Point of Care Diagnostics Market during the forecast period, 2022 to 2027. Owing to significance of key growth factors such as rising prevalence of infectious diseases, growing technological advancements pertaining to the Point of Care Diagnostics, rising geriatric population associated with reduced immunity and increasingly susceptible to infectious diseases with the rising focus of the government in terms of providing access to healthcare solutions catering to such indications, the North America point of care diagnostics market is expected to witness positive growth.
Point of Care Diagnostics Market By Product Type (Instruments, Reagents And Kits), By Application (Blood Glucose Monitoring, Infectious Disease, Cardio Metabolic Diseases, Pregnancy & Infertility Testing, And Others), By Technology (Lateral Flow Assays, Immunoassays, Molecular Diagnostics, And Others), By End-User (Hospitals, Diagnostic Centers, Home Care Settings, And Others), and by geography is estimated to register appreciable CAGR forecast till 2027 owing to the increasing prevalence of infectious diseases and rising technological advancements pertaining to the point of care diagnostic devices
Global Point of Care Diagnostics market was valued at USD 1.85 billion in 2021, growing at a CAGR of 7.99% during the forecast period from 2022 to 2027 to reach USD 2.93 billion by 2027. The demand for point of care diagnostics is primarily being boosted by the rising number of patients suffering from various infectious diseases, rising prevalence of diabetes, increasing frequency of both chronic and acute diseases, increasing demand of point of care kits in the diseases management of COVID-19 infection, and the increasing technological advancements associated with the Point of Care Diagnostic devices will help in driving the overall market growth of point of care diagnostics during the forecast period from 2022-2027.
Point of Care Diagnostics Market Dynamics:
The point of care diagnostics market is experiencing increase in product demand owing to a variety of factors. One of the important factors is the emergence of COVID-19. The rising prevalence of COVID-19 across the globe can be attributed to increase in demand of point of care diagnostic devices owing to the rising use of POC kits in COVID-19 detection. As per the World Health Organization February 28, 2022, there have been 434,154,739 confirmed cases of COVID-19, thereby there will be an increase in the demand of point of care, leading to an overall growth of the point of care devices market.
Furthermore, the rising number of patients having diabetes will also increase the demand of point of care diagnostic devices, further leading to an increase in the overall market growth of the point of care diagnostic devices. For instance, according to the International Diabetes Federation, in the year 2022, approximately 537 million adults (20-79 years) were suffering from diabetes. Also, as per the same source, the total number of people living with diabetes is projected to rise to 643 million by the year 2030 and 785 million by 2045 which will boost the market growth during the forecast period.
However, several stringent regulatory policies pertaining to the Point of Care Diagnostics and the inadequate adoption of point of care diagnostics may restrict the point of care diagnostics market growth.
The point of care diagnostics market has been affected positively after the emergence of the COVID-19 infection. Although the COVID-19 pandemic impact had been unforeseen and devastating, however the point of care diagnostics demand was positively influenced, as the POC diagnostic were rapidly used in the detection of COVID-19. The rapidly rising number of COVID-19 cases and the rising pressure on the government for improving patient management has further boosted the demand for rapid antigen testing kits that can be effectively used in point-of-care settings. Such rapidly detecting kit of point of care diagnostic are important in offering accurate disease management options. Therefore, owing to an increase in the demand for speedy diagnostic results, the adoption of point of care devices amongst the patients is continuously on the rise.
Point of Care Diagnostics Market Segment Analysis:
Point Of Care Diagnostics Market By Product Type (Instruments, Reagents and Kits), By Application (Blood Glucose Monitoring, Infectious Disease, Cardio Metabolic Diseases, Pregnancy & Infertility Testing, and Others), By Technology (Lateral Flow Assays, Immunoassays, Molecular Diagnostics, and Others), By End-User (Hospitals, Diagnostic Centers, Home Care Settings, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the application segment of the point of care diagnostics market, the infectious disease category is expected to amass a significant share in the market revenue during the forecast period. This can be ascribed to various factors such as the rising prevalence of COVID-19, rising product approvals pertaining to infectious diseases point of care diagnostics, rising research and development associated with POC kits that help in the diagnosis of infectious diseases across the world.
For example, as per the Our World in Data organization, in 2022, around 296 million people were living with chronic hepatitis B infection in the year 2019, affecting about 1.5 million people with infections every year. Owing to a rise in the population suffering from chronic hepatitis B, there will be an increase in the demand of point of care diagnostic devices, leading to an overall increase in the point of care diagnostics market growth.
Furthermore, as per the World Health Organization 2022, every year, an estimated 11-20 million people tend to get affected from typhoid and about 128,000 to 161,000 people were affected from it. Owing to an increase in the number of patients suffering from typhoid, there will be an increase in the demand of point of care diagnostic devices, driving the market growth of Point of Care Diagnostics.
Moreover, an increase in the number of product approvals used in the disease diagnosis of infectious diseases and other chronic diseases will also increase the demand of point of care diagnostics sued in disease assessment, leading to the overall growth of point of care diagnostic devices.
Thus, all the aforementioned factors are likely to propel the infectious diseases category growth in the point of care diagnostics devices market during the forecast period.
North America is expected to dominate the overall Point of Care Diagnostics Market:
Among all the regions, North America is estimated to account for the largest share in the point of care diagnostics market. Owing to the significance of key growth factors such as rising prevalence of geriatric population susceptible to developing chronic diseases such as infectious diseases owing to reduced immunity, increasing presence of key players in the region, favorable government scenario, rising awareness associated with self-testing and rising demand of home care testing, growing approvals for Point of Care Diagnostic devices in the North American region coupled with increasing focus of the government in terms of providing access to healthcare services catering to such indications will drive the market growth in the region.
Several collaborations and strategic partnerships between the key players, along with higher adoption of advanced rapid diagnostic solutions in the North American region will increase the demand of POC diagnostic solutions, leading to an overall increase in the market growth of point of care diagnostics market growth. Also, the continued investments made in research and development activities along with a strong portfolio of products in the point-of-care testing segment, are likely to continue fueling the instances of point of care diagnostics devices, thereby generating demand for Point of Care Diagnostics.
Furthermore, the rising emergency use authorization for expanded access will also contribute to the growing demand of point of care devices, causing the overall increase of the point of care devices market growth. For instance, on December 25, 2022, Roche COVID-19 at-home test had received FDA emergency use authorization to expand access for rapid self-testing solutions in the United States.
Furthermore, the rise in the number of patients suffering from diabetes will also lead to an increase in the demand of point of care diagnostics devices, thereby leading to an overall rise of the point of care diagnostics market growth. For instance, according to the Centers of Disease Control and Prevention 2022, in the year 2022, around 37.3 million people were suffering from diabetes, that had accounted to about 11.3% of the US population. As per the same source, in the year 2022, around 28.7 million people, accounting to about 28.5 million adults were diagnosed for diabetes in the United States.
Thus, all the above mentioned factors will lead to an increase in the North America Point of Care Diagnostics market.
Point of Care Diagnostics Market Key Players:
Some of the key market players operating in the point of care diagnostics market includes Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Becton Dickinson and Company, Abbott Laboratories, Quidel Diagnostics, Chembio Diagnostics, EKF Diagnostics, Trinity Biotech, and Fluxergy, Qiagen, Mesa Biotech, Cepheid, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Quidel Corporation, Bio-Rad Laboratories Inc. and others.
Recent Developmental Activities in Point of Care Diagnostics Market:
- On November 12, 2022, iHealth Labs had received the FDA Emergency Use Authorization for over-the-counter sale of the COVID-19 Antigen Rapid Test.
- On June 28, 2022, Abbott had received the CE Mark for their Panbio rapid antigen self-test, opening access throughout Europe for faster and reliable COVID-19 testing.
- On October 11, 2022, Takara Bio Europe had received CE-IVD Mark for COVID-19 Diagnostic kit, SARS-CoV-2 Direct polymerase chain-reaction (PCR) diagnostic detection kit.
- On February 24, 2022, Cue Health’s point-of-care Covid-19 test had obtained a CE Mark. The Cue COVID-19 test is a highly sensitive and specific Nucleic Acid Amplification Test (NAAT) that works on the Cue Health Monitoring System.
- Market size analysis for current point of care diagnostics market size (2021), and market forecast for 5 years (2022-2027)
- The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the point of care diagnostics market.
- Top key product/services/Technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
- Key companies dominating the Global Point of Care Diagnostics Market.
- Various opportunities available for the other competitor in the Point of Care Diagnostics Market space.
- What are the top performing segments in 2021? How these segments will perform in 2027.
- Which is the top-performing regions and countries in the current point of care diagnostics market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for point of care diagnostics market growth in the coming future?
- Point of Care Diagnostics Market products providers
- Research organizations and consulting companies
- Point of Care Diagnostics Market -related organizations, associations, forums, and other alliances
- Government and corporate offices
- Start-up companies, venture capitalists, and private equity firms
- Distributors and Traders dealing in Point of Care Diagnostics Market
- Various End-users who want to know more about the Point of Care Diagnostics Market and latest technological developments in the Point of Care Diagnostics Market.
1. What are Point of Care Diagnostics Market?
Point of care (POC) diagnostic devices are used to obtain diagnostic results while with the patient or close to the patient. Used in doctors’ offices, hospitals, and in patients' homes, POC diagnostic devices give quick feedback on many sorts of medical tests.
2. What is the market for Global Point of Care Diagnostics Market?
Global point of care diagnostics market was valued at USD 1.85 billion in 2021, growing at a CAGR of 7.99% during the forecast period from 2022 to 2027 to reach USD 2.93 billion by 2027.
3. What are the drivers for Global Point of Care Diagnostics Market?
The demand for point of care diagnostics is primarily being boosted by increasing prevalence of infectious diseases, rising prevalence of pregnancies, rising technological advancements pertaining to the Point of Care Diagnostics, and the rising geriatric population associated with reduced immunity and a rise in infectious diseases thereby contributing in the overall growth of the point of care diagnostics market during the forecast period from 2022-2027.
4. Who are the key players operating in Global Point of Care Diagnostics Market?
Some of the key market players operating in the point of care diagnostics market includes Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Becton Dickinson and Company, Abbott Laboratories, Quidel Diagnostics, Chembio Diagnostics, EKF Diagnostics, Trinity Biotech, and Fluxergy, Qiagen, Mesa Biotech, Cepheid, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Quidel Corporation, Bio-Rad Laboratories Inc., and others.
5. Which region has the highest share in Point of Care Diagnostics Market?
North America is expected to dominate the overall Point of Care Diagnostics Market during the forecast period, 2022 to 2027. Owing to significance of key growth factors such as rising prevalence of infectious diseases, growing technological advancements pertaining to the Point of Care Diagnostics, rising geriatric population associated with reduced immunity and increasingly susceptible to infectious diseases with the rising focus of the government in terms of providing access to healthcare solutions catering to such indications, the North America point of care diagnostics market is expected to witness positive growth.
1.POINT OF CARE DIAGNOSTICS MARKET REPORT INTRODUCTION
2.POINT OF CARE DIAGNOSTICS MARKET EXECUTIVE SUMMARY
2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment
3. REGULATORY ANALYSIS
3.1. The United States
3.2. Europe
3.3. Japan
3.4. China
4. POINT OF CARE DIAGNOSTICS MARKET KEY FACTORS ANALYSIS
4.1. Point of Care Diagnostics Market Drivers
4.1.1. Increasing prevalence of infectious diseases such as COVID-19
4.1.2. Increasing prevalence of hepatitis B
4.1.3. Rising technological advancements pertaining to the Point of Care Diagnostics
4.1.4. Faster Turn-around time of Point of Care Diagnostic Devices
4.2. Point of Care Diagnostics Market Restraints and Challenges
4.2.1. Less Awareness regarding the Point of Care Diagnostics
4.2.2. Cost associated with Point of Care Diagnostics
4.3. Point of Care Diagnostics Market Opportunities
4.3.1. Increasing popularity of Point of Care Devices
4.3.2. Healthcare Decentralization in several countries
5. POINT OF CARE DIAGNOSTICS MARKET PORTER’S FIVE FORCES ANALYSIS
5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry
6. COVID-19 IMPACT ANALYSIS ON POINT OF CARE DIAGNOSTICS MARKET
7. POINT OF CARE DIAGNOSTICS MARKET LAYOUT
7.1. By Product Type
7.1.1. Instruments
7.1.2. Kits and Reagents
7.2. By Application
7.2.1. Blood Glucose Monitoring
7.2.2. Infectious Disease
7.2.3. Cardio Metabolic Diseases
7.2.4. Pregnancy & Infertility Testing
7.2.5. Others
7.3. By Technology
7.3.1. Lateral Flow Assays
7.3.2. Immunoassays
7.3.3. Molecular Diagnostics
7.3.4. Others
7.4. By End User
7.4.1. Hospitals
7.4.2. Diagnostic centres
7.4.3. Home care settings
7.4.4. Others
7.5. By Geography
7.5.1 North America
7.5.1.1. North America Point of Care Diagnostics Market, by Product Type
7.5.1.2. North America Point of Care Diagnostics Market, by Application
7.5.1.3. North America Point of Care Diagnostics Market, by Technology
7.5.1.4. North America Point of Care Diagnostics Market, by End-User
7.5.1.5. North America Point of Care Diagnostics Market, by Country
7.5.1.5.1. United States
7.5.1.5.2. Canada
7.5.1.5.3. Mexico
7.5.2. Europe
7.5.2.1. Europe Point of Care Diagnostics Market, by Product Type
7.5.2.2. Europe Point of Care Diagnostics Market, by Application
7.5.2.3. Europe Point of Care Diagnostics Market, by Technology
7.5.2.4. Europe Point of Care Diagnostics Market, by End-User
7.5.2.5. Europe Point of Care Diagnostics Market, by Country
7.5.2.5.1. France
7.5.2.5.2. Germany
7.5.2.5.3. United Kingdom
7.5.2.5.4. Italy
7.5.2.5.5. Spain
7.5.2.5.6. Russia
7.5.2.5.7. Rest of Europe
7.5.3. Asia-Pacific
7.5.3.1. Asia-Pacific Point of Care Diagnostics Market, by Product Type
7.5.3.2. Asia-Pacific Point of Care Diagnostics Market, by Application
7.5.3.3. Asia-Pacific Point of Care Diagnostics Market, by Technology
7.5.3.4. Asia-Pacific Point of Care Diagnostics Market, by End-User
7.5.3.5. Asia-Pacific Point of Care Diagnostics Market, by Country
7.5.3.5.1. China
7.5.3.5.2. Japan
7.5.3.5.3. India
7.5.3.5.4. Australia
7.5.3.5.5. South Korea
7.5.3.5.6. Rest of Asia Pacific
7.5.4. Rest of the World (RoW)
7.5.4.1. Rest of the World (RoW) Point of Care Diagnostics Market, by Product Type
7.5.4.2. Rest of the World (RoW) Point of Care Diagnostics Market, by Application
7.5.4.3. Rest of the World (RoW) Point of Care Diagnostics Market, by Technology
7.5.4.4. Rest of the World (RoW) Point of Care Diagnostics Market, by End-User
7.4.4.5. Rest of the World (RoW) Point of Care Diagnostics Market, by Country
7.4.4.5.1. Middle East
7.4.4.5.2. Africa
7.4.4.5.3. South America
8. POINT OF CARE DIAGNOSTICS MARKET COMPANY AND PRODUCT PROFILES
8.1. Roche Diagnostics
8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Financial Overview
8.1.4. Product Listing
8.1.5. Entropy
8.2. Siemens Healthineers
8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Financial Overview
8.2.4. Product Listing
8.2.5. Entropy
8.3. Danaher Corporation
8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Financial Overview
8.3.4. Product Listing
8.3.5. Entropy
8.4. Becton Dickinson and Company
8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Financial Overview
8.4.4. Product Listing
8.4.5. Entropy
8.5. Abbott Laboratories
8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Financial Overview
8.5.4. Product Listing
8.5.5. Entropy
8.6. Quidel Diagnostics
8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Financial Overview
8.6.4. Product Listing
8.6.5. Entropy
8.7. Chembio Diagnostics
8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Financial Overview
8.7.4. Product Listing
8.7.5. Entropy
8.8. EKF Diagnostics
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Financial Overview
8.8.4. Product Listing
8.8.5. Entropy
8.9. Trinity Biotech
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Financial Overview
8.8.4. Product Listing
8.8.5. Entropy
8.10. Fluxergy
8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Financial Overview
8.10.4. Product Listing
8.10.5. Entropy
8.11. Qiagen
8.11.1. Company Overview
8.11.2. Company Snapshot
8.11.3. Financial Overview
8.11.4. Product Listing
8.11.5. Entropy
8.12. Mesabiotech
8.12.1. Company Overview
8.12.2. Company Snapshot
8.12.3. Financial Overview
8.12.4. Product Listing
8.12.5. Entropy
9. KOL VIEWS
10. PROJECT APPROACH
11. ABOUT DELVEINSIGHT
12. DISCLAIMER & CONTACT US
2.POINT OF CARE DIAGNOSTICS MARKET EXECUTIVE SUMMARY
2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment
3. REGULATORY ANALYSIS
3.1. The United States
3.2. Europe
3.3. Japan
3.4. China
4. POINT OF CARE DIAGNOSTICS MARKET KEY FACTORS ANALYSIS
4.1. Point of Care Diagnostics Market Drivers
4.1.1. Increasing prevalence of infectious diseases such as COVID-19
4.1.2. Increasing prevalence of hepatitis B
4.1.3. Rising technological advancements pertaining to the Point of Care Diagnostics
4.1.4. Faster Turn-around time of Point of Care Diagnostic Devices
4.2. Point of Care Diagnostics Market Restraints and Challenges
4.2.1. Less Awareness regarding the Point of Care Diagnostics
4.2.2. Cost associated with Point of Care Diagnostics
4.3. Point of Care Diagnostics Market Opportunities
4.3.1. Increasing popularity of Point of Care Devices
4.3.2. Healthcare Decentralization in several countries
5. POINT OF CARE DIAGNOSTICS MARKET PORTER’S FIVE FORCES ANALYSIS
5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry
6. COVID-19 IMPACT ANALYSIS ON POINT OF CARE DIAGNOSTICS MARKET
7. POINT OF CARE DIAGNOSTICS MARKET LAYOUT
7.1. By Product Type
7.1.1. Instruments
7.1.2. Kits and Reagents
7.2. By Application
7.2.1. Blood Glucose Monitoring
7.2.2. Infectious Disease
7.2.3. Cardio Metabolic Diseases
7.2.4. Pregnancy & Infertility Testing
7.2.5. Others
7.3. By Technology
7.3.1. Lateral Flow Assays
7.3.2. Immunoassays
7.3.3. Molecular Diagnostics
7.3.4. Others
7.4. By End User
7.4.1. Hospitals
7.4.2. Diagnostic centres
7.4.3. Home care settings
7.4.4. Others
7.5. By Geography
7.5.1 North America
7.5.1.1. North America Point of Care Diagnostics Market, by Product Type
7.5.1.2. North America Point of Care Diagnostics Market, by Application
7.5.1.3. North America Point of Care Diagnostics Market, by Technology
7.5.1.4. North America Point of Care Diagnostics Market, by End-User
7.5.1.5. North America Point of Care Diagnostics Market, by Country
7.5.1.5.1. United States
7.5.1.5.2. Canada
7.5.1.5.3. Mexico
7.5.2. Europe
7.5.2.1. Europe Point of Care Diagnostics Market, by Product Type
7.5.2.2. Europe Point of Care Diagnostics Market, by Application
7.5.2.3. Europe Point of Care Diagnostics Market, by Technology
7.5.2.4. Europe Point of Care Diagnostics Market, by End-User
7.5.2.5. Europe Point of Care Diagnostics Market, by Country
7.5.2.5.1. France
7.5.2.5.2. Germany
7.5.2.5.3. United Kingdom
7.5.2.5.4. Italy
7.5.2.5.5. Spain
7.5.2.5.6. Russia
7.5.2.5.7. Rest of Europe
7.5.3. Asia-Pacific
7.5.3.1. Asia-Pacific Point of Care Diagnostics Market, by Product Type
7.5.3.2. Asia-Pacific Point of Care Diagnostics Market, by Application
7.5.3.3. Asia-Pacific Point of Care Diagnostics Market, by Technology
7.5.3.4. Asia-Pacific Point of Care Diagnostics Market, by End-User
7.5.3.5. Asia-Pacific Point of Care Diagnostics Market, by Country
7.5.3.5.1. China
7.5.3.5.2. Japan
7.5.3.5.3. India
7.5.3.5.4. Australia
7.5.3.5.5. South Korea
7.5.3.5.6. Rest of Asia Pacific
7.5.4. Rest of the World (RoW)
7.5.4.1. Rest of the World (RoW) Point of Care Diagnostics Market, by Product Type
7.5.4.2. Rest of the World (RoW) Point of Care Diagnostics Market, by Application
7.5.4.3. Rest of the World (RoW) Point of Care Diagnostics Market, by Technology
7.5.4.4. Rest of the World (RoW) Point of Care Diagnostics Market, by End-User
7.4.4.5. Rest of the World (RoW) Point of Care Diagnostics Market, by Country
7.4.4.5.1. Middle East
7.4.4.5.2. Africa
7.4.4.5.3. South America
8. POINT OF CARE DIAGNOSTICS MARKET COMPANY AND PRODUCT PROFILES
8.1. Roche Diagnostics
8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Financial Overview
8.1.4. Product Listing
8.1.5. Entropy
8.2. Siemens Healthineers
8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Financial Overview
8.2.4. Product Listing
8.2.5. Entropy
8.3. Danaher Corporation
8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Financial Overview
8.3.4. Product Listing
8.3.5. Entropy
8.4. Becton Dickinson and Company
8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Financial Overview
8.4.4. Product Listing
8.4.5. Entropy
8.5. Abbott Laboratories
8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Financial Overview
8.5.4. Product Listing
8.5.5. Entropy
8.6. Quidel Diagnostics
8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Financial Overview
8.6.4. Product Listing
8.6.5. Entropy
8.7. Chembio Diagnostics
8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Financial Overview
8.7.4. Product Listing
8.7.5. Entropy
8.8. EKF Diagnostics
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Financial Overview
8.8.4. Product Listing
8.8.5. Entropy
8.9. Trinity Biotech
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Financial Overview
8.8.4. Product Listing
8.8.5. Entropy
8.10. Fluxergy
8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Financial Overview
8.10.4. Product Listing
8.10.5. Entropy
8.11. Qiagen
8.11.1. Company Overview
8.11.2. Company Snapshot
8.11.3. Financial Overview
8.11.4. Product Listing
8.11.5. Entropy
8.12. Mesabiotech
8.12.1. Company Overview
8.12.2. Company Snapshot
8.12.3. Financial Overview
8.12.4. Product Listing
8.12.5. Entropy
9. KOL VIEWS
10. PROJECT APPROACH
11. ABOUT DELVEINSIGHT
12. DISCLAIMER & CONTACT US
LIST OF TABLES
Table 1: Competitive Analysis
Table 2: COVID-19 Impact Analysis
Table 3: Point of Care Diagnostics Market in Global (2019-2027)
Table 4: Point of Care Diagnostics Market in Global by Product Type (2019-2027)
Table 5: Point of Care Diagnostics Market in Global by Application (2019-2027)
Table 6: Point of Care Diagnostics Market in Global by Technology (2019-2027)
Table 8: Point of Care Diagnostics Market in Global by End User (2019-2027)
Table 9: Point of Care Diagnostics Market in North America by Product Type (2019-2027)
Table 10: Point of Care Diagnostics Market in North America by Application (2019-2027)
Table 11: Point of Care Diagnostics Market in North America by Technology (2019-2027)
Table 12: Point of Care Diagnostics Market in North America by End User (2019-2027)
Table 13: Point of Care Diagnostics Market in North America by Geography (2019-2027)
Table 14: Point of Care Diagnostics Market in North America by Country (2019-2027)
Table 15: Point of Care Diagnostics Market in the US (2019-2027)
Table 16: Point of Care Diagnostics Market in Canada (2019-2027)
Table 17: Point of Care Diagnostics Market in Mexico (2019-2027)
Table 18: Point of Care Diagnostics Market in Europe by Product Type (2019-2027)
Table 20: Point of Care Diagnostics Market in Europe by Application (2019-2027)
Table 21: Point of Care Diagnostics Market in Europe by Technology (2019-2027)
Table 22: Point of Care Diagnostics Market in Europe by End User (2019-2027)
Table 23: Point of Care Diagnostics Market in Europe by Country (2019-2027)
Table 24: Point of Care Diagnostics Market in France (2019-2027)
Table 25: Point of Care Diagnostics Market in Germany (2019-2027)
Table 26: Point of Care Diagnostics Market in the United Kingdom (2019-2027)
Table 27: Point of Care Diagnostics Market in Italy (2019-2027)
Table 28: Point of Care Diagnostics Market in Spain (2019-2027)
Table 29: Point of Care Diagnostics Market in Russia (2019-2027)
Table 30: Point of Care Diagnostics Market in Rest of Europe (2019-2027)
Table 31: Point of Care Diagnostics Market in APAC (2019-2027)
Table 33: Point of Care Diagnostics Market in APAC by Product Type (2019-2027)
Table 34: Point of Care Diagnostics Market in APAC by Application (2019-2027)
Table 35: Point of Care Diagnostics Market in APAC by Technology (2019-2027)
Table 36: Point of Care Diagnostics Market in APAC by End User (2019-2027)
Table 37: Point of Care Diagnostics Market in China (2019-2027)
Table 38: Point of Care Diagnostics Market in Japan (2019-2027)
Table 39: Point of Care Diagnostics Market in India (2019-2027)
Table 40: Point of Care Diagnostics Market in Australia (2019-2027)
Table 41: Point of Care Diagnostics Market in South Korea (2019-2027)
Table 42: Point of Care Diagnostics Market in Rest of APAC (2019-2027)
Table 43: Point of Care Diagnostics Market in Rest of World (2019-2027)
Table 44: Point of Care Diagnostics Market in Rest of World by Product Type (2019-2027)
Table 45: Point of Care Diagnostics Market in Rest of World by Application (2019-2027)
Table 46: Point of Care Diagnostics Market in Rest of World by Technology (2019-2027)
Table 47: Point of Care Diagnostics Market in Rest of World by End User (2019-2027)
Table 48: Point of Care Diagnostics Market in Middle East (2019-2027)
Table 49: Point of Care Diagnostics Market in Africa (2019-2027)
Table 50: Point of Care Diagnostics Market in South America (2019-2027)
Table 1: Competitive Analysis
Table 2: COVID-19 Impact Analysis
Table 3: Point of Care Diagnostics Market in Global (2019-2027)
Table 4: Point of Care Diagnostics Market in Global by Product Type (2019-2027)
Table 5: Point of Care Diagnostics Market in Global by Application (2019-2027)
Table 6: Point of Care Diagnostics Market in Global by Technology (2019-2027)
Table 8: Point of Care Diagnostics Market in Global by End User (2019-2027)
Table 9: Point of Care Diagnostics Market in North America by Product Type (2019-2027)
Table 10: Point of Care Diagnostics Market in North America by Application (2019-2027)
Table 11: Point of Care Diagnostics Market in North America by Technology (2019-2027)
Table 12: Point of Care Diagnostics Market in North America by End User (2019-2027)
Table 13: Point of Care Diagnostics Market in North America by Geography (2019-2027)
Table 14: Point of Care Diagnostics Market in North America by Country (2019-2027)
Table 15: Point of Care Diagnostics Market in the US (2019-2027)
Table 16: Point of Care Diagnostics Market in Canada (2019-2027)
Table 17: Point of Care Diagnostics Market in Mexico (2019-2027)
Table 18: Point of Care Diagnostics Market in Europe by Product Type (2019-2027)
Table 20: Point of Care Diagnostics Market in Europe by Application (2019-2027)
Table 21: Point of Care Diagnostics Market in Europe by Technology (2019-2027)
Table 22: Point of Care Diagnostics Market in Europe by End User (2019-2027)
Table 23: Point of Care Diagnostics Market in Europe by Country (2019-2027)
Table 24: Point of Care Diagnostics Market in France (2019-2027)
Table 25: Point of Care Diagnostics Market in Germany (2019-2027)
Table 26: Point of Care Diagnostics Market in the United Kingdom (2019-2027)
Table 27: Point of Care Diagnostics Market in Italy (2019-2027)
Table 28: Point of Care Diagnostics Market in Spain (2019-2027)
Table 29: Point of Care Diagnostics Market in Russia (2019-2027)
Table 30: Point of Care Diagnostics Market in Rest of Europe (2019-2027)
Table 31: Point of Care Diagnostics Market in APAC (2019-2027)
Table 33: Point of Care Diagnostics Market in APAC by Product Type (2019-2027)
Table 34: Point of Care Diagnostics Market in APAC by Application (2019-2027)
Table 35: Point of Care Diagnostics Market in APAC by Technology (2019-2027)
Table 36: Point of Care Diagnostics Market in APAC by End User (2019-2027)
Table 37: Point of Care Diagnostics Market in China (2019-2027)
Table 38: Point of Care Diagnostics Market in Japan (2019-2027)
Table 39: Point of Care Diagnostics Market in India (2019-2027)
Table 40: Point of Care Diagnostics Market in Australia (2019-2027)
Table 41: Point of Care Diagnostics Market in South Korea (2019-2027)
Table 42: Point of Care Diagnostics Market in Rest of APAC (2019-2027)
Table 43: Point of Care Diagnostics Market in Rest of World (2019-2027)
Table 44: Point of Care Diagnostics Market in Rest of World by Product Type (2019-2027)
Table 45: Point of Care Diagnostics Market in Rest of World by Application (2019-2027)
Table 46: Point of Care Diagnostics Market in Rest of World by Technology (2019-2027)
Table 47: Point of Care Diagnostics Market in Rest of World by End User (2019-2027)
Table 48: Point of Care Diagnostics Market in Middle East (2019-2027)
Table 49: Point of Care Diagnostics Market in Africa (2019-2027)
Table 50: Point of Care Diagnostics Market in South America (2019-2027)
LIST OF FIGURES
Figure 1 Competitive Analysis
Figure 2 COVID-19 Impact Analysis
Figure 3: Point of Care Diagnostics Market in Global (2019-2027)
Figure 4: Point of Care Diagnostics Market in Global by Product Type (2019-2027)
Figure 5: Point of Care Diagnostics Market in Global by Application (2019-2027)
Figure 6: Point of Care Diagnostics Market in Global by Technology (2019-2027)
Figure 8: Point of Care Diagnostics Market in Global by End User (2019-2027)
Figure 9: Point of Care Diagnostics Market in North America by Product Type (2019-2027)
Figure 10: Point of Care Diagnostics Market in North America by Application (2019-2027)
Figure 11: Point of Care Diagnostics Market in North America by Technology (2019-2027)
Figure 12: Point of Care Diagnostics Market in North America by End User (2019-2027)
Figure 13: Point of Care Diagnostics Market in North America by Geography (2019-2027)
Figure 14: Point of Care Diagnostics Market in North America by Country (2019-2027)
Figure 15: Point of Care Diagnostics Market in the US (2019-2027)
Figure 16: Point of Care Diagnostics Market in Canada (2019-2027)
Figure 17: Point of Care Diagnostics Market in Mexico (2019-2027)
Figure 18: Point of Care Diagnostics Market in Europe by Product Type (2019-2027)
Figure 20: Point of Care Diagnostics Market in Europe by Application (2019-2027)
Figure 21: Point of Care Diagnostics Market in Europe by Technology (2019-2027)
Figure 22: Point of Care Diagnostics Market in Europe by End User (2019-2027)
Figure 23: Point of Care Diagnostics Market in Europe by Country (2019-2027)
Figure 24: Point of Care Diagnostics Market in France (2019-2027)
Figure 25: Point of Care Diagnostics Market in Germany (2019-2027)
Figure 26: Point of Care Diagnostics Market in the United Kingdom (2019-2027)
Figure 27: Point of Care Diagnostics Market in Italy (2019-2027)
Figure 28: Point of Care Diagnostics Market in Spain (2019-2027)
Figure 29: Point of Care Diagnostics Market in Russia (2019-2027)
Figure 30: Point of Care Diagnostics Market in Rest of Europe (2019-2027)
Figure 31: Point of Care Diagnostics Market in APAC (2019-2027)
Figure 33: Point of Care Diagnostics Market in APAC by Product Type (2019-2027)
Figure 34: Point of Care Diagnostics Market in APAC by Application (2019-2027)
Figure 35: Point of Care Diagnostics Market in APAC by Technology (2019-2027)
Figure 36: Point of Care Diagnostics Market in APAC by End User (2019-2027)
Figure 37: Point of Care Diagnostics Market in China (2019-2027)
Figure 38: Point of Care Diagnostics Market in Japan (2019-2027)
Figure 39: Point of Care Diagnostics Market in India (2019-2027)
Figure 40: Point of Care Diagnostics Market in Australia (2019-2027)
Figure 41: Point of Care Diagnostics Market in South Korea (2019-2027)
Figure 42: Point of Care Diagnostics Market in Rest of APAC (2019-2027)
Figure 43: Point of Care Diagnostics Market in Rest of World (2019-2027)
Figure 44: Point of Care Diagnostics Market in Rest of World by Product Type (2019-2027)
Figure 45: Point of Care Diagnostics Market in Rest of World by Application (2019-2027)
Figure 46: Point of Care Diagnostics Market in Rest of World by Technology (2019-2027)
Figure 47: Point of Care Diagnostics Market in Rest of World by End User (2019-2027)
Figure 48: Point of Care Diagnostics Market in Middle East (2019-2027)
Figure 49: Point of Care Diagnostics Market in Africa (2019-2027)
Figure 50: Point of Care Diagnostics Market in South America (2019-2027)
Figure 1 Competitive Analysis
Figure 2 COVID-19 Impact Analysis
Figure 3: Point of Care Diagnostics Market in Global (2019-2027)
Figure 4: Point of Care Diagnostics Market in Global by Product Type (2019-2027)
Figure 5: Point of Care Diagnostics Market in Global by Application (2019-2027)
Figure 6: Point of Care Diagnostics Market in Global by Technology (2019-2027)
Figure 8: Point of Care Diagnostics Market in Global by End User (2019-2027)
Figure 9: Point of Care Diagnostics Market in North America by Product Type (2019-2027)
Figure 10: Point of Care Diagnostics Market in North America by Application (2019-2027)
Figure 11: Point of Care Diagnostics Market in North America by Technology (2019-2027)
Figure 12: Point of Care Diagnostics Market in North America by End User (2019-2027)
Figure 13: Point of Care Diagnostics Market in North America by Geography (2019-2027)
Figure 14: Point of Care Diagnostics Market in North America by Country (2019-2027)
Figure 15: Point of Care Diagnostics Market in the US (2019-2027)
Figure 16: Point of Care Diagnostics Market in Canada (2019-2027)
Figure 17: Point of Care Diagnostics Market in Mexico (2019-2027)
Figure 18: Point of Care Diagnostics Market in Europe by Product Type (2019-2027)
Figure 20: Point of Care Diagnostics Market in Europe by Application (2019-2027)
Figure 21: Point of Care Diagnostics Market in Europe by Technology (2019-2027)
Figure 22: Point of Care Diagnostics Market in Europe by End User (2019-2027)
Figure 23: Point of Care Diagnostics Market in Europe by Country (2019-2027)
Figure 24: Point of Care Diagnostics Market in France (2019-2027)
Figure 25: Point of Care Diagnostics Market in Germany (2019-2027)
Figure 26: Point of Care Diagnostics Market in the United Kingdom (2019-2027)
Figure 27: Point of Care Diagnostics Market in Italy (2019-2027)
Figure 28: Point of Care Diagnostics Market in Spain (2019-2027)
Figure 29: Point of Care Diagnostics Market in Russia (2019-2027)
Figure 30: Point of Care Diagnostics Market in Rest of Europe (2019-2027)
Figure 31: Point of Care Diagnostics Market in APAC (2019-2027)
Figure 33: Point of Care Diagnostics Market in APAC by Product Type (2019-2027)
Figure 34: Point of Care Diagnostics Market in APAC by Application (2019-2027)
Figure 35: Point of Care Diagnostics Market in APAC by Technology (2019-2027)
Figure 36: Point of Care Diagnostics Market in APAC by End User (2019-2027)
Figure 37: Point of Care Diagnostics Market in China (2019-2027)
Figure 38: Point of Care Diagnostics Market in Japan (2019-2027)
Figure 39: Point of Care Diagnostics Market in India (2019-2027)
Figure 40: Point of Care Diagnostics Market in Australia (2019-2027)
Figure 41: Point of Care Diagnostics Market in South Korea (2019-2027)
Figure 42: Point of Care Diagnostics Market in Rest of APAC (2019-2027)
Figure 43: Point of Care Diagnostics Market in Rest of World (2019-2027)
Figure 44: Point of Care Diagnostics Market in Rest of World by Product Type (2019-2027)
Figure 45: Point of Care Diagnostics Market in Rest of World by Application (2019-2027)
Figure 46: Point of Care Diagnostics Market in Rest of World by Technology (2019-2027)
Figure 47: Point of Care Diagnostics Market in Rest of World by End User (2019-2027)
Figure 48: Point of Care Diagnostics Market in Middle East (2019-2027)
Figure 49: Point of Care Diagnostics Market in Africa (2019-2027)
Figure 50: Point of Care Diagnostics Market in South America (2019-2027)
